TxSCO is raising its advocacy voice on state and federal issues.

We are actively working to ensure that the voice of oncology in Texas is heard. Explore our website for the latest updates in oncology and healthcare-related legislation in Texas, discover TxSCO's advocacy on the state and federal level, and more. 

TxSCO values your input. Help us make a difference in our state. Do you know a Texas State Legislature member? Do you have an issue you want to bring attention to? Please send all questions and comments to Stephanie Van Winkle, Executive Director.

State Advocacy

TxSCO Joins ASCO in Support Letter for HB 293

The Texas Society of Clinical Oncology (TxSCO) and the Association for Clinical Oncology (ASCO) are pleased to support House Bill 293: Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans, which would provide coverage for fertility preservation services for patients with cancer when necessary medical treatments may cause infertility. The House Insurance Committee’s passage of HB 293 would be a crucial step in helping to make Texas the 11th state to provide this important protection for patients with cancer. Read support letter

Posted 03/18/2021

 

Federal Advocacy

Federal and State Advocacy Updates—August 2022
    • Federal
      • Inflation Reduction Act
      • PHE Extended Through Oct. 13, 2022
      • Telehealth Activity
    • State
      • House Select Committee on HC Hearing
      • Upcoming SHHS Hearing
      • Update from Speaker's Leadership Team

    View Full Report

     
Federal and State Advocacy Updates—July 2022
    • Federal
      • New CMMI Oncology Model: EOM
      • PFS Proposed Rule for 2023
      • Drug Pricing Legislative Reforms: The Latest
      • Appendix
    • State
      • Dobbs Impact
      • House Public Health
      • Mental Health
      • Updated BRE
      • General Election Polling

    View Full Report

     
Federal and State Advocacy Updates—June 2022
    • Federal
      • Political Timeline: Where we're at
      • PBMs: Oncology drug formulary exclusions on the rise as federal scrutiny continues
      • ACA Exchange Subsidies: Expanded eligibility and generosity expire year-end, 3 million projected to become uninsured
    • State
      • House Insurance Committee Hearing
      • Upcoming Hearings of Interest
      • Uvalde Shootings
      • Health Families, Healthy Texas

    View Full Report

     

Update for MIPS-Eligible Clinicians Affected by Extreme Circumstances

In response to the Federal Emergency Management Agency (FEMA) designation of the Texas Severe Winter Storm as a national disaster, the Centers for Medicare & Medicaid Services has determined that the automatic extreme and uncontrollable circumstances policy will apply to Merit-based Incentive Payment System (MIPS) eligible clinicians in FEMA-identified Texas areas.

MIPS-eligible clinicians in these areas will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. During the data submission period for the 2021 performance period (January 3, 2022 to March 31, 2022), all four performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold. Click here for more information.

Posted 05/13/2021

 

Oncology State Societies at ACCC: Snapshot from the 2022 ASCO Annual Meeting

In this clip, Stephanie Van Winkle, Executive Director of the Oncology State Societies at ACCC, gives an overview of the important work the Oncology State Societies does to empower its members around state and federal advocacy issues, and help them support cancer care delivery in their state. Join today


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
txsco.com
Email Us